Literature DB >> 20670812

Epidemiology of atopic dermatitis and atopic march in children.

Jonathan M Spergel1.   

Abstract

Atopic dermatitis (AD) is one of the most common chronic childhood skin diseases affecting up to 17% of children in the United States. The point prevalence of AD has increased based on validated questionnaires in the most recent update of the International Study of Asthma and Allergies in Childhood. However, the increases are primarily in developing countries, whereas the rates have stabilized in countries with higher incomes. AD starts in early childhood with 65% of children affected by 18 months of age. Furthermore, less than half of the patients with AD have complete resolution by 7 years of age and only 60% have resolution by adulthood, indicating the chronic nature of AD. AD is a major risk factor for the development of asthma, with an increased odds ratio in children with AD in several longitudinal studies compared with children without AD, and about 30% of patients with AD develop asthma. Patients with atopic sensitization along with eczema are at a higher risk for progressing in the atopic march to asthma. The main risk factors for progression and persistence of asthma are early onset and severity of AD. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20670812     DOI: 10.1016/j.iac.2010.06.003

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  60 in total

1.  Comorbidity in Atopic Dermatitis.

Authors:  Eric L Simpson
Journal:  Curr Dermatol Rep       Date:  2012-03-01

2.  Helicobacter pylori in allergic and non-allergic rhinitis does play a protective or causative role?

Authors:  Umur Akiner; H Murat Yener; E Deniz Gozen; S Burcu Kuzu; Salih Canakcioglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-25       Impact factor: 2.503

3.  [Not Available].

Authors:  Firas George Hougeir; Fran E Cook-Bolden; David Rodriguez; Joshua M Berlin
Journal:  J Clin Aesthet Dermatol       Date:  2015-05

4.  Co-Activation of Glucocorticoid Receptor and Peroxisome Proliferator-Activated Receptor-γ in Murine Skin Prevents Worsening of Atopic March.

Authors:  Julie Deckers; Nadia Bougarne; Viacheslav Mylka; Sofie Desmet; Astrid Luypaert; Michael Devos; Giel Tanghe; Justine Van Moorleghem; Manon Vanheerswynghels; Lode De Cauwer; Jonathan Thommis; Marnik Vuylsteke; Jan Tavernier; Bart N Lambrecht; Hamida Hammad; Karolien De Bosscher
Journal:  J Invest Dermatol       Date:  2017-12-27       Impact factor: 8.551

5.  Asthma and frequency of wheeze: risk factors for the persistence of atopic dermatitis in children.

Authors:  Jackie P-D Garrett; Andrea J Apter; Ole Hoffstad; Jonathan M Spergel; David J Margolis
Journal:  Ann Allergy Asthma Immunol       Date:  2013-01-16       Impact factor: 6.347

Review 6.  SLIT's Prevention of the Allergic March.

Authors:  Federica Porcaro; Giovanni Corsello; Giovanni Battista Pajno
Journal:  Curr Allergy Asthma Rep       Date:  2018-04-21       Impact factor: 4.806

Review 7.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

8.  Prevalence and risk factors for atopic disease in a population of preschool children in Rome: Challenges to early intervention.

Authors:  Luciana Indinnimeo; Daniela Porta; Francesco Forastiere; Valentina De Vittori; Giovanna De Castro; Anna Maria Zicari; Giancarlo Tancredi; Taulant Melengu; Marzia Duse
Journal:  Int J Immunopathol Pharmacol       Date:  2016-03-02       Impact factor: 3.219

9.  Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies.

Authors:  Fatima Bawany; Lisa A Beck; Kirsi M Järvinen
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03

10.  Effect of non-human neutral and acidic oligosaccharides on allergic and infectious diseases in preterm infants.

Authors:  Nicky Niele; Annelies van Zwol; Elisabeth A M Westerbeek; Harrie N Lafeber; Ruurd M van Elburg
Journal:  Eur J Pediatr       Date:  2012-11-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.